Pharmacokinetics of ADS-5102 (Amantadine) Extended Release Capsules Administered Once Daily at Bedtime for the Treatment of Dyskinesia

BACKGROUND: Preclinical and clinical studies suggest amantadine immediate-release (IR) may reduce dyskinesia in Parkinson’s disease (PD), although higher doses are associated with increased CNS adverse events (AEs). ADS-5102 is an extended release amantadine capsule formulation, designed for once-da...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Pharmacokinet
Main Authors: Hauser, Robert A., Pahwa, Rajesh, Wargin, William A., Souza-Prien, Cindy J., McClure, Natalie, Johnson, Reed, Nguyen, Jack T., Patni, Rajiv, Went, Gregory T.
Format: Artigo
Sprog:Inglês
Udgivet: Springer International Publishing 2018
Fag:
Original Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325984/
https://ncbi.nlm.nih.gov/pubmed/29777529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-018-0663-4
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker